Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains.

van Gemst JJ, Kouwenberg M, Rops ALWMM, van Kuppevelt TH, Berden JH, Rabelink TJ, Loeven MA, van der Vlag J.

PLoS One. 2018 Sep 24;13(9):e0201560. doi: 10.1371/journal.pone.0201560. eCollection 2018.

2.

Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition.

Pieterse E, Rother N, Garsen M, Hofstra JM, Satchell SC, Hoffmann M, Loeven MA, Knaapen HK, van der Heijden OWH, Berden JHM, Hilbrands LB, van der Vlag J.

Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1371-1379. doi: 10.1161/ATVBAHA.117.309002. Epub 2017 May 11.

PMID:
28495931
3.

RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues.

van Gemst JJ, Loeven MA, de Graaf MJ, Berden JH, Rabelink TJ, Smit CH, van der Vlag J.

PLoS One. 2016 Nov 29;11(11):e0167336. doi: 10.1371/journal.pone.0167336. eCollection 2016.

4.

Sildenafil Prevents Podocyte Injury via PPAR-γ-Mediated TRPC6 Inhibition.

Sonneveld R, Hoenderop JG, Isidori AM, Henique C, Dijkman HB, Berden JH, Tharaux PL, van der Vlag J, Nijenhuis T.

J Am Soc Nephrol. 2017 May;28(5):1491-1505. doi: 10.1681/ASN.2015080885. Epub 2016 Nov 28.

5.

Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis.

Dieker J, Berden JH, Bakker M, Briand JP, Muller S, Voll R, Sjöwall C, Herrmann M, Hilbrands LB, van der Vlag J.

PLoS One. 2016 Oct 25;11(10):e0165373. doi: 10.1371/journal.pone.0165373. eCollection 2016.

6.

Cathepsin L is crucial for the development of early experimental diabetic nephropathy.

Garsen M, Rops AL, Dijkman H, Willemsen B, van Kuppevelt TH, Russel FG, Rabelink TJ, Berden JH, Reinheckel T, van der Vlag J.

Kidney Int. 2016 Nov;90(5):1012-1022. doi: 10.1016/j.kint.2016.06.035. Epub 2016 Aug 26.

PMID:
27575559
7.

Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria.

Garsen M, Rops AL, Li J, van Beneden K, van den Branden C, Berden JH, Rabelink TJ, van der Vlag J.

PLoS One. 2016 Aug 9;11(8):e0160894. doi: 10.1371/journal.pone.0160894. eCollection 2016.

8.

Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.

Garsen M, Lenoir O, Rops AL, Dijkman HB, Willemsen B, van Kuppevelt TH, Rabelink TJ, Berden JH, Tharaux PL, van der Vlag J.

J Am Soc Nephrol. 2016 Dec;27(12):3545-3551. Epub 2016 Mar 29.

9.

Coexistence of systemic lupus erythematosus, tuberous sclerosis and aggressive natural killer-cell leukaemia: coincidence or correlated?

Olde Bekkink M, Ahmed-Ousenkova YM, Netea MG, van der Velden WJ, Berden JH.

Lupus. 2016 Jun;25(7):766-71. doi: 10.1177/0961203316636466. Epub 2016 Mar 4.

PMID:
26946293
10.

Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.

Garsen M, Benner M, Dijkman HB, van Kuppevelt TH, Li JP, Rabelink TJ, Vlodavsky I, Berden JH, Rops AL, Elkin M, van der Vlag J.

Am J Pathol. 2016 Apr;186(4):805-15. doi: 10.1016/j.ajpath.2015.12.008. Epub 2016 Feb 9.

PMID:
26873445
11.

1,25-Vitamin D3 Deficiency Induces Albuminuria.

Sonneveld R, Hoenderop JG, Stavenuiter AW, Ferrantelli E, Baltissen MP, Dijkman HB, Florquin S, Rops AL, Wetzels JF, Berden JH, van der Vlag J, Nijenhuis T.

Am J Pathol. 2016 Apr;186(4):794-804. doi: 10.1016/j.ajpath.2015.11.015. Epub 2016 Feb 3.

PMID:
26851346
12.

Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis.

Tsang-A-Sjoe MW, Nagelkerke SQ, Bultink IE, Geissler J, Tanck MW, Tacke CE, Ellis JA, Zenz W, Bijl M, Berden JH, de Leeuw K, Derksen RH, Kuijpers TW, Voskuyl AE.

Rheumatology (Oxford). 2016 May;55(5):939-48. doi: 10.1093/rheumatology/kev433. Epub 2016 Jan 8.

PMID:
26748351
13.

Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.

Loeven MA, Rops AL, Lehtinen MJ, van Kuppevelt TH, Daha MR, Smith RJ, Bakker M, Berden JH, Rabelink TJ, Jokiranta TS, van der Vlag J.

J Biol Chem. 2016 Mar 4;291(10):4974-81. doi: 10.1074/jbc.M115.702506. Epub 2016 Jan 4.

14.

Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.

Dieker J, Schlumberger W, McHugh N, Hamann P, van der Vlag J, Berden JH.

Mol Immunol. 2015 Nov;68(1):20-4. doi: 10.1016/j.molimm.2015.06.004.

PMID:
26597199
15.

Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.

Dieker J, Tel J, Pieterse E, Thielen A, Rother N, Bakker M, Fransen J, Dijkman HB, Berden JH, de Vries JM, Hilbrands LB, van der Vlag J.

Arthritis Rheumatol. 2016 Feb;68(2):462-72. doi: 10.1002/art.39417.

16.

Differential Expression of Specific Dermatan Sulfate Domains in Renal Pathology.

Lensen JF, van der Vlag J, Versteeg EM, Wetzels JF, van den Heuvel LP, Berden JH, van Kuppevelt TH, Rops AL.

PLoS One. 2015 Aug 31;10(9):e0134946. doi: 10.1371/journal.pone.0134946. eCollection 2015.

17.

Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.

Garsen M, Sonneveld R, Rops AL, Huntink S, van Kuppevelt TH, Rabelink TJ, Hoenderop JG, Berden JH, Nijenhuis T, van der Vlag J.

J Pathol. 2015 Dec;237(4):472-81. doi: 10.1002/path.4593. Epub 2015 Aug 31.

PMID:
26202309
18.

Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice.

Dieker J, Hilbrands L, Thielen A, Dijkman H, Berden JH, van der Vlag J.

Arthritis Res Ther. 2015 Apr 16;17:103. doi: 10.1186/s13075-015-0617-2.

19.

Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.

Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M; Dutch Working Party on SLE.

Neth J Med. 2014 Nov;72(9):481-90.

20.

The role of heparan sulfate as determining pathogenic factor in complement factor H-associated diseases.

Loeven MA, Rops AL, Berden JH, Daha MR, Rabelink TJ, van der Vlag J.

Mol Immunol. 2015 Feb;63(2):203-8. doi: 10.1016/j.molimm.2014.08.005. Epub 2014 Sep 20. Review.

PMID:
25246018
21.

TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy.

Hofstra JM, Coenen MJ, Schijvenaars MM, Berden JH, van der Vlag J, Hoefsloot LH, Knoers NV, Wetzels JF, Nijenhuis T.

PLoS One. 2014 Jul 14;9(7):e102065. doi: 10.1371/journal.pone.0102065. eCollection 2014.

22.

To TDM or not to TDM in lupus nephritis patients treated with MMF?

van Gelder T, Berden JH, Berger SP.

Nephrol Dial Transplant. 2015 Apr;30(4):560-4. doi: 10.1093/ndt/gfu184. Epub 2014 May 8. Review.

PMID:
24811231
23.

Modulation of heparan sulfate in the glomerular endothelial glycocalyx decreases leukocyte influx during experimental glomerulonephritis.

Rops AL, Loeven MA, van Gemst JJ, Eversen I, Van Wijk XM, Dijkman HB, van Kuppevelt TH, Berden JH, Rabelink TJ, Esko JD, van der Vlag J.

Kidney Int. 2014 Nov;86(5):932-42. doi: 10.1038/ki.2014.115. Epub 2014 Apr 23.

24.

Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.

Sonneveld R, van der Vlag J, Baltissen MP, Verkaart SA, Wetzels JF, Berden JH, Hoenderop JG, Nijenhuis T.

Am J Pathol. 2014 Jun;184(6):1715-26. doi: 10.1016/j.ajpath.2014.02.008. Epub 2014 Apr 13.

PMID:
24731445
25.

The role of heparanase and the endothelial glycocalyx in the development of proteinuria.

Garsen M, Rops AL, Rabelink TJ, Berden JH, van der Vlag J.

Nephrol Dial Transplant. 2014 Jan;29(1):49-55. doi: 10.1093/ndt/gft410. Epub 2013 Oct 28. Review.

PMID:
24166469
26.

Renal heparan sulfate proteoglycans modulate fibroblast growth factor 2 signaling in experimental chronic transplant dysfunction.

Katta K, Boersema M, Adepu S, Rienstra H, Celie JWAM, Mencke R, Molema G, van Goor H, Berden JHM, Navis G, Hillebrands JL, van den Born J.

Am J Pathol. 2013 Nov;183(5):1571-1584. doi: 10.1016/j.ajpath.2013.07.030. Epub 2013 Sep 11.

PMID:
24035513
27.

Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.

Sonneveld R, Ferrè S, Hoenderop JG, Dijkman HB, Berden JH, Bindels RJ, Wetzels JF, van der Vlag J, Nijenhuis T.

Am J Pathol. 2013 Apr;182(4):1196-204. doi: 10.1016/j.ajpath.2012.12.011. Epub 2013 Feb 4.

PMID:
23385000
28.

Anti-ribosomal P antibodies as a single serological marker in SLE: lupus in disguise.

Kleinnijenhuis J, van der Molen RG, Franssen PM, Berden JH, van der Meer JW, Jacobs JF.

Scand J Rheumatol. 2013;42(2):165-6. doi: 10.3109/03009742.2012.754941. Epub 2013 Feb 5. No abstract available.

PMID:
23379479
29.

New TRPC6 gain-of-function mutation in a non-consanguineous Dutch family with late-onset focal segmental glomerulosclerosis.

Hofstra JM, Lainez S, van Kuijk WH, Schoots J, Baltissen MP, Hoefsloot LH, Knoers NV, Berden JH, Bindels RJ, van der Vlag J, Hoenderop JG, Wetzels JF, Nijenhuis T.

Nephrol Dial Transplant. 2013 Jul;28(7):1830-8. doi: 10.1093/ndt/gfs572. Epub 2013 Jan 4.

PMID:
23291369
30.

Idiopathic giant oesophageal ulcer and leucopoenia after renal transplantation.

van Boekel GA, Volbeda M, van den Hoogen MW, Hilbrands LB, Berden JH.

Neth J Med. 2012 Oct;70(8):370-3.

31.

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, Ferrario F, Floege J, Houssiau FA, Ioannidis JP, Isenberg DA, Kallenberg CG, Lightstone L, Marks SD, Martini A, Moroni G, Neumann I, Praga M, Schneider M, Starra A, Tesar V, Vasconcelos C, van Vollenhoven RF, Zakharova H, Haubitz M, Gordon C, Jayne D, Boumpas DT; European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association.

Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31.

32.

Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis.

van Tellingen A, Voskuyl AE, Vervloet MG, Bijl M, de Sévaux RG, Berger SP, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

Neth J Med. 2012 May;70(4):199-207. Review.

33.

Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.

Martens HA, Nienhuis HL, Gross S, van der Steege G, Brouwer E, Berden JH, de Sévaux RG, Derksen RH, Voskuyl AE, Berger SP, Navis GJ, Nolte IM, Kallenberg CG, Bijl M.

Lupus. 2012 Aug;21(9):959-68. doi: 10.1177/0961203312444495. Epub 2012 Apr 18.

PMID:
22513366
34.

Effect of administration of apoptotic blebs on disease development in lupus mice.

Fransen JH, Berden JH, Koeter CM, Adema GJ, Van Der Vlag J, Hilbrands LB.

Autoimmunity. 2012 Jun;45(4):290-7. doi: 10.3109/08916934.2012.664668. Epub 2012 Apr 2.

PMID:
22390780
35.

Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.

Rops AL, van den Hoven MJ, Veldman BA, Salemink S, Vervoort G, Elving LD, Aten J, Wetzels JF, van der Vlag J, Berden JH.

Nephrol Dial Transplant. 2012 Jul;27(7):2853-61. doi: 10.1093/ndt/gfr732. Epub 2011 Dec 20.

PMID:
22187315
36.

Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.

Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH; Dutch Working Party on systemic lupus erythematosus.

Ann Rheum Dis. 2012 Jun;71(6):966-73. doi: 10.1136/annrheumdis-2011-200384. Epub 2011 Nov 29.

PMID:
22128082
37.

Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes.

Haring CM, Rietveld A, van den Brand JA, Berden JH.

J Am Soc Nephrol. 2012 Jan;23(1):149-54. doi: 10.1681/ASN.2011060558. Epub 2011 Oct 27.

38.

Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation.

O'Flynn J, Flierman R, van der Pol P, Rops A, Satchell SC, Mathieson PW, van Kooten C, van der Vlag J, Berden JH, Daha MR.

Mol Immunol. 2011 Oct;49(1-2):75-83. doi: 10.1016/j.molimm.2011.07.020. Epub 2011 Aug 19.

PMID:
21855148
39.

Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer RA, Möller CC, Hamming I, Navis G, Wetzels JF, Berden JH, Reiser J, Faul C, van der Vlag J.

Am J Pathol. 2011 Oct;179(4):1719-32. doi: 10.1016/j.ajpath.2011.06.033. Epub 2011 Aug 11.

40.

Lupus nephritis: role of antinucleosome autoantibodies.

van der Vlag J, Berden JH.

Semin Nephrol. 2011 Jul;31(4):376-89. doi: 10.1016/j.semnephrol.2011.06.009. Review.

PMID:
21839371
41.

Treatment of lupus nephritis.

Dolff S, Berden JH, Bijl M.

Expert Rev Clin Immunol. 2010 Nov;6(6):901-11. doi: 10.1586/eci.10.79. Review.

PMID:
20979555
42.

Synchronized turbo apoptosis induced by cold-shock.

Fransen JH, Dieker JW, Hilbrands LB, Berden JH, van der Vlag J.

Apoptosis. 2011 Jan;16(1):86-93. doi: 10.1007/s10495-010-0546-0.

43.

Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes.

van Bavel CC, Dieker JW, Tamboer WP, van der Vlag J, Berden JH.

Mol Immunol. 2010 Nov-Dec;48(1-3):248-56. doi: 10.1016/j.molimm.2010.08.003.

PMID:
20817300
44.

Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus.

van Bavel CC, Dieker JW, Kroeze Y, Tamboer WP, Voll R, Muller S, Berden JH, van der Vlag J.

Ann Rheum Dis. 2011 Jan;70(1):201-7. doi: 10.1136/ard.2010.129320. Epub 2010 Aug 10.

PMID:
20699234
45.

Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.

Martens HA, Gross S, van der Steege G, Brouwer E, Berden JH, de Sevaux R, Derksen RH, Voskuyl AE, Berger SP, Navis GJ, Kallenberg CG, Bijl M.

J Rheumatol. 2010 Nov;37(11):2226-31. doi: 10.3899/jrheum.091468. Epub 2010 Aug 3.

PMID:
20682662
46.

The role of dendritic cells in the pathogenesis of systemic lupus erythematosus.

Fransen JH, van der Vlag J, Ruben J, Adema GJ, Berden JH, Hilbrands LB.

Arthritis Res Ther. 2010;12(2):207. doi: 10.1186/ar2966. Epub 2010 Apr 26. Review.

47.

Reversible rapidly progressive dementia with parkinsonism induced by valproate in a patient with systemic lupus erythematosus.

Sleegers MJ, Beutler JJ, Hardon WJ, Berden JH, Verhave JC, Conemans JM, Hollander DA, Dautzenberg PL, Hoogeveen EK.

J Am Geriatr Soc. 2010 Apr;58(4):799-801. doi: 10.1111/j.1532-5415.2010.02795.x. No abstract available.

PMID:
20398172
48.

The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.

Rops AL, Figdor CG, van der Schaaf A, Tamboer WP, Bakker MA, Berden JH, Dijkman HB, Steenbergen EJ, van der Vlag J, van Spriel AB.

Am J Pathol. 2010 May;176(5):2188-97. doi: 10.2353/ajpath.2010.090770. Epub 2010 Mar 26.

49.

Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.

Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D'Cruz DP, Isenberg DA, Rahman A.

Arthritis Res Ther. 2009 Oct 14;11(5):R154. doi: 10.1186/ar2831.

50.

Both early and late apoptotic blebs are taken up by DC and induce IL-6 production.

Fransen JH, Hilbrands LB, Jacobs CW, Adema GJ, Berden JH, Van der Vlag J.

Autoimmunity. 2009 May;42(4):325-7.

PMID:
19811290

Supplemental Content

Loading ...
Support Center